Important Notice for ADMA Biologics Shareholders: Class Action Opportunity

Attention Shareholders of ADMA Biologics, Inc.

If you hold shares in ADMA Biologics, Inc. (NASDAQ: ADMA), it's important to be aware of a securities class action lawsuit currently in progress. The Gross Law Firm has announced an alert directed towards shareholders who purchased shares between August 9, 2024, and March 25, 2026. This notice serves to inform you of the possibility of joining the legal proceedings as a potential lead plaintiff or simply seeking recovery without any obligation.

Details of the Class Action

The lawsuit alleges that during the specified class period, ADMA Biologics made materially false statements and engaged in misconduct that significantly impacted its stock price and the interests of its shareholders. Key allegations include:
1. Undisclosed Related Party Transaction: ADMA is accused of failing to disclose a related party transaction that could have affected investors' decisions.
2. Channel Stuffing Practices: The company reportedly engaged in practices referred to as channel stuffing to artificially inflate its revenue figures, ultimately misleading investors regarding the health and performance of the company.
3. Lack of Internal Controls: It is further claimed that ADMA did not have adequate internal controls in place, raising concerns over the legitimacy of its financial reporting.

Because of these allegations, the statements made by the company regarding its business operations and future prospects have been deemed materially false and misleading.

Deadline for Shareholders

To ensure you are included in this class action, it’s vital to register before the upcoming deadline of August 10, 2026. Shareholders who do not act soon may miss the opportunity to participate in recovering potential losses. Registration is simple and can be done through the link provided: Register Here. Once registered, you will also gain access to portfolio monitoring software that will keep you updated on the status of your case.

Why Choose The Gross Law Firm?

The Gross Law Firm is a well-respected class action attorney firm known for its commitment to protecting investors' rights. They aim to hold corporations accountable for practices that result in deceptive actions leading to financial loss among shareholders. The firm has extensive experience in securing recovery for investors affected by false or misleading corporate conduct.

Contact Information

If you believe you have been impacted by the alleged actions of ADMA Biologics, do not hesitate to reach out for assistance or clarification regarding your rights as a shareholder. You can contact The Gross Law Firm by visiting their website or by directly calling:

- Phone: (646) 453-8903
- Address: 15 West 38th Street, 12th floor, New York, NY, 10018

Make sure to take this opportunity seriously. The window to act is closing, and your investment rights should not be overlooked.

Conclusion

In summary, if you are a shareholder of ADMA Biologics, it's prudent to reach out to The Gross Law Firm to discuss your options regarding the ongoing class action. By taking timely action, you may join your fellow investors in seeking justice and compensation for losses incurred during the specified class period.